International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 557-564
Research Article
A Study of Clinical Profile and Outcome of Bronchiolitis in Children of Age 1–24 Months at A Tertiary Care Hospital in South India
 ,
 ,
 ,
Received
Jan. 12, 2026
Accepted
Feb. 20, 2026
Published
March 12, 2026
Abstract

Bronchiolitis is one of biggest clinical problem in children less than 2 years of age. Aims and objectives: . This study was done to outline the clinical profile of acute bronchiolitis as well as the risk factors for mortality and severe illness in children aged 1-24 months. Methodology: This is a Prospective Observational study conducted at Rangaraya Medical College and Government General Hospital, Kakinada, over a period of 12 months from October 2022 to September 2023.Results: A total of 200 cases were enrolled. Majority of the children were of the age 1-6 months (58.5%). Male preponderance was seen with M:F ratio 1.4:1. Children were admitted more during the winter months (Dec-Feb) 45%. Mild bronchiolitis was seen in majority children (83%). Severity was more among the 1-6 months age group, with severity decreasing with increasing age. Risk factors like birth weight less than 2.5 kgs, lack of exclusive breastfeeding, bottle, passive smoking, large family size with more than 4 family members, families with higher birth order, and families belonging to lower classes of socioeconomic status had increased severity of bronchiolitis, which was statistically significant. The mortality rate of bronchiolitis in the study was 6.5%. Conclusion: Bronchiolitis contributes to significant morbidity and mortality in infants. Parents should be counseled regarding modifiable risk factors which can increase the severity of illness. A vaccine against RSV can be effective in decreasing the disease burden in infants.

Keywords
INTRODUCTION

Bronchiolitis is a constellation of clinical symptoms and signs, including a viral upper respiratory prodrome followed by increased respiratory effort and wheezing in children less than 2 years of age, and it is one of the biggest clinical problems in pediatric care. 50% to 75% of hospitalized children under the age of two years who had bronchiolitis had the respiratory syncytial virus [1].Children were also found to harbor other common viral respiratory pathogens, like influenza, parainfluenza, and adenovirus.[2, 3]. Bronchiolitis is linked to a high degree of morbidity but low mortality (<1%), making it one of the most common reasons for newborns and younger children to be admitted to the hospital. With a peak incidence between three and six months of age, it typically manifests between one month and twenty-four months of age. At the moment, not enough information is available to estimate the prevalence of bronchiolitis in developing and underdeveloped nations.

 

In young, healthy infants and children, acute bronchiolitis typically resolves on its own, with most of these cases requiring only supportive measures. Most of these children start getting better in a week or two. However, in certain children, it can result in fatalities and serious illness. Numerous medical conditions, including prematurity, low birth weight, chronic lung disease, congenital heart disease, and immunodeficiency (acquired and congenital), increase the risk of the disease getting worse. Furthermore, a multitude of non-medical factors also contribute to the disease  severity, increasing the likelihood of hospitalization. Feeding habits (breastfeeding or bottle feeding), family history of asthma, passive smoking, indoor allergens (wood burning stove and mosquito coils), crowding, number of siblings in the family, and lower socioeconomic status are the non-medical risk factors. It is necessary to stress how crucial it is to prevent non- medical risk factors in order to lower the rate of hospitalization and shorten hospital stays. This study outlines the clinical profile of acute bronchiolitis at our hospital as well as the risk factors for mortality and severe illness in children aged 1-24 months.

 

MATERIALS AND METHODS

Study Design: This is a Prospective Observational study conducted at Rangaraya Medical College and Government General Hospital, Kakinada, over a period of 12 months from October 2022 to September 2023, after approval by the Institutional Ethics Committee (IEC), Rangaraya Medical College, Kakinada, with registration no.ECR/1384/Inst/AP/2020. Sampling Technique: Simple Random Sampling Study. Subjects & Sample Size: Based on Indian studies on bronchiolitis in 1-24 months children sample size was calculated to approximately 199 children.

 

n=Z2 p(1-p)                n= 1.962. 0.153 . 0.86= 199

d2                                                0.052

 

A total of200 children aged 1month to 24 months admitted in GGH, Kakinada, with a clinical diagnosis of bronchiolitis whose guardians/caregivers gave informed consent to participate in the study were included.

 

Inclusion Criteria:

  • Previously normal children aged 1 – 24 months admitted with clinical features of bronchiolitis
  • (Clinical definition of bronchiolitis: A constellation of clinical symptoms and signs
  • including a viral upper respiratory prodrome followed by increased respiratory effort and
  • wheezing in children less than 2 years of age)
  • First episode of wheeze suggestive of bronchiolitis as per AAP Guidelines.

 

Exclusion criteria:

Children with underlying chronic respiratory or cardiovascular diseases, like CLDCongenital heart disease, myocarditis.

 

METHODOLOGY:

Written informed consent was taken from the parents / caregivers of the patients. All babies in the age group of 1 to 24 months with a first episode of acute respiratory illness were screened for bacterial sepsis by doing Total leukocyte count, C-reactive protein, and CXR . Children showing clinical features of bacterial sepsis were excluded from the study. Details of enrolled children were entered in a pre-designed proforma. Demographic details like age, sex, socioeconomic status, type of family, exposure to Indoor allergens, passive smoking, family history of asthma, and child details like birth weight, breastfeeding or not, duration of illness were noted. Clinical Severity of Respiratory illness was assessed using the Woods Downes score. Children who scored below 3 are classified as mild cases, 4-7 are classified as moderate, and 8- 14 are classified as severe cases. Hypoxemia was assessed by pulse oximetry. Children with oxygen saturation below 92% on room air were admitted and treated under PICU care, rest were treated in the ward. They were given Protocol treatment, followed throughout the hospital stay, and the final outcome was noted.

 

Wood Downes Score

Score

Wheezing

Retraction

RR

HR

Ventilation

cyanosis

0

No

No

<30

<120

Good
Symmetrical

No

1

End
expiratory

Sub costal/
intercostal

31-45

>120

Regular
Symmetrical

Yes

2

All
expiratory

Supraclavicular
+ nasal flaring

45-60

-

Very
reduced

-


3

Both inspiration and
expiration

intercostal+ suprasternal


>60

 

-

Silent thorax


-

 

Duration of oxygen requirement and duration of hospital stay were analyzed.

 

Statistical Analysis:

Patient data were analyzed using SPSS 23.0 software. Microsoft Word and MS Excel were used to generate graphs, tables, etc. A chi-square test was used to compare differences between categorical variables. For comparison between the means, the Wilcoxon matched-pairs test was used, and the Student's t-test was used. For interpretation of results, significance shall be adopted at p-value < 0.05 at a 95% confidence interval.

 

RESULTS

A total of 200 cases were enrolled in this study.

 

Table No. 1: Shows Demographic details of the children.

 

Children

Children

Age (In months)

No.

%

1–6

117

58.5%

7-12

60

30%

13–18

18

9%

19-24

5

2.5%

Gender

   

Male

117

58.5

Female

83

41.5

Seasonal Pattern

   

Season-Months

   

Autumn (Sep-Nov)

64

32%

Winter (Dec-Feb)

90

45%

Summer (Mar-May)

29

14.5%

Rainy (Jun-Aug)

17

8.5%

Jul-23

5

2.5%

Aug-23

7

3.5%

Sep-23

18

9.0%

Severity

   

Mild

83

41.5%

Moderate

82

41.0%

Severe

35

17.5%

 

The majority of enrolled children belonged to the age group of 1-6months (58.5%). 7- 12 months, 13-18 months, and 19-24 months constituted for 30%, 9%, and 2.5%, respectively. Bronchiolitis was more commonly seen in males (117) than females (83) with a ratio of 1.4:1. Children were admitted with bronchiolitis more commonly during the winter months of December to February (90) and Autumn (September to November-64) followed by Summer (29) and Rainy seasons (17). 41.5% (83) of children had mild, 41% (82) had moderate, and 17.5% (35) had a severe type of bronchiolitis.

 

Table No 2: Severity of bronchiolitis among different age groups and gender of children

Age

 

(In months)

Mild

Mild

Moderate

Moderate

Severe

Severe

 

Age

 

(In months)

No.

%

No.

%

No.

%

Total

1–6

38

32.5%

56

47.9%

23

19.6%

117

7–12

30

50%

19

31.7%

11

18.3%

60

13-18

12

66.7%

5

27.7%

1

5.6%

18

19-24

3

60%

2

40%

0

0.0%

5

 

p= 0.03, Significant

 

Gender

Mild

Mild

Moderate

Moderate

Severe

Severe

 
 

No.

%

No.

%

No.

%

Total

Male

53

45.3%

46

39.3%

18

15.4%

117

Female

30

36.1%

36

43.4%

17

20.5%

83

p=0.29, not Significant

 

Severity was more among the 1-6 months age group, with severity decreasing with increasing age. A statistically significant relationship is present between age and severity (p= 0.03, Significant) while the gender of the child did not have statistical significance (p=0.29, not significant).

 

Table 3: Risk factors vs Severity of bronchiolitis.

Risk Factor

 

Severity

Severity

Severity

   

Mild

Moderate

Severe

Birth Weight

<2.5kg (%),n=74

18(24.3%)

37(50%)

19(25.7%)

Birth Weight

>2.5 kg(%),n=126

65(51.6%)

45(35.7%)

16(12.7%)

p=0.0003,Significant

Exclusive breastfeeding

Yes(%),n=84

40(47.6%)

40(47.6%)

4(4.8%)

Exclusive breastfeeding

No(%),n=116

43(37%)

42(36.2%)

31(26.8%)

p=0.001,Significant

Parental Asthma

Yes(%),n=42

15(35.7%)

19(45.2%)

8(19%)

Parental Asthma

No(%),n=158

68(43%)

63(39.9%)

27(17%)

p=0.69, not significant

Passive Smoking

Yes(%),n=90

29(32.2%)

39(43.3%)

22(24.4%)

Passive Smoking

No(%),n=110

54(49.1%)

43(39.1%)

13(11.8%)

p=0.02, not significant

Family Size >4 members

Yes(%),n=95

30(31.6%)

43(45.3%)

22(23.1%)

Family Size >4 members

No(%),n=105

53(50.5%)

39(37.1%)

13(12.4%)

p=0.02,Significant

No of children >2

Yes(%),n=71

22(31%)

29(40.8%)

20(28.1%)

No of children >2

No(%),n=129

61(47.2%)

53(41.1%)

15(11.6%)

p=0.02,Significant

Socioeconomic status

Class I
n=0

-

-

-

Socioeconomic status

Class II
n=2

2(100%)

-

-

Socioeconomic status

Class III
n=64

34(53.1%)

26(40.6%)

4(6.3%)

Socioeconomic status

Class IV
N=119

43(36.1%)

49(41.2%)

27(22.7%)

Socioeconomic status

Class V
n=15

4(26.6%)

7(46.7%)

4(26.7%)

p=0.01, Significant

 

Risk factors like birth weight less than 2.5 kgs, lack of exclusive breastfeeding, bottle, passive smoking, large family size with more than 4 family members, families with higher birth order, and families belonging to lower classes of socioeconomic status had increased severity of bronchiolitis, which was statistically significant. No significant statistical significance was seen between parental asthma and severity of bronchiolitis (p=0.69)

 

Table 4: Oxygen requirement and Duration of hospital stay vs Severity of the disease.

   

Severity of Disease

Severity of Disease

Severity of Disease

   

Mild

Moderate

Severe

Oxygen Requirement

<72hours
n=107

79(95%)

28(34.15%)

0(0%)

Oxygen Requirement

>72hours
N=93

4(5%)

54(65.85%)

35(100%)

p=0.001, Significant

Duration of Hospital stay.

<7 days
n=185

80(96.38%)

79(96.34%)

26(74.28%)

Duration of Hospital stay.

>7 days
n=15

3(3.6%)

3(3.65%)

9(25.71%)

p=0.001, Significant

 

The average duration of O2 supplementation was 2.36 days in this study. Severe cases needed prolonged oxygen requirement, which was statistically significant (p=0.001).

 

The mean duration of hospital stay was 4 days. Severe cases of bronchiolitis needed a longer stay in hospital than mild and moderate cases, which was statistically significant (p=0.001).

 

Table 5 : Outcomes among different age groups and degree of severity.

 

Survived

Deceased

Age Group

   

1-6 months

109(93.2%)

8(6.8%)

7-12 months

56(93.3%)

4(6.7%)

13-18 months

17(94.4%)

1(5.6%)

19-24 months

5(100%)

0(0%)

p-value is 0.816. The result is not significant .

Severity

   

Mild

83(100%)

-

Moderate

77(93.9%)

5(6.09%)

Severe

27(77.1%)

8(22.9%)

p-valueis.000123,significant.

 

The mortality rate of bronchiolitis in the study was 6.5%. There is no statistically significant difference in mortality among various age groups. The mortality is significantly high in severe cases.

 

DISCUSSION

200 children in the age group of 1-24 months with clinical features of bronchiolitis were enrolled in the present study.

 

According to Joseph L. Mathew et al. [4], bronchiolitis is thought to be the most prevalent LRTI among infants in developed nations. Based on how frequently young infants experienced wheezing episodes, it is evident that this is a serious issue in our nation as well.

 

In studies by Caroline Breese Halletal. [5] and Uyan et al. [6],85% of children belonged to less than 12 months.88.2% and 68.5% of children were less than 12 months in studies by Chidambaranathan S et al and Tarik AS et al from Tamil Nadu, South India, and Bangladesh, respectively[7,8]. In the present  study, nearly 88.5% (177) were in the 1–12 month age group, and 11.5% of the children were between the ages of 12 and 24 months, which is similar to a study by P.Flores et al [9] in which 10.6% children belonged to the 12–24 month age range . This shows that as age increases occurrence of bronchiolitis decreases

 

The mean age of the children in this study was 6.3 months, which is comparable to the study by Uyan et al[6], where the mean age was 6.9 months. The mean age was 5.43 months, 5.98 months, and 5 months in studies by Arif A et al[10] ,A.G.Constantopoulos et al [11], and R.Y.T. Sung et al[12]. The mean age was higher in studies by Iqbal et al(11.5 months) [13] and Premkumar B et al(10.8 months)[14]. This can be explained by the fact that bronchiolitis most frequently affects age groups between five and seven months.

 

In this study, male preponderance( male-to-female ratio ,1.4:1,) was seen which is consistent with reports from other regions of the world [12,13]. The male-to-female ratio was 1.32:1, 1.38:1,1.35:1,1.36:1 in studies by Chidambaranathan et al. [7], Ekoub et al[15], Naamnih et al[16], and Osman et al[17]. Anatomically, male infants have inherently narrow airways, which get blocked easily due to inflammation when infected with viral infections like RSV. Differences in innate immune responses to viral respiratory infections can be another reason for the higher prevalence in male than female children.

 

In the present study majority of the cases were reported during the winter months(December to February 45%).Bronchiolitis outbreaks are most likely to happen in the winter and early spring.RSV infections are more common during the winter months in tropical climates, in contrast to temperate regions[18].62% cases were reported during the months November to February in the study by Tarik AS et al[8].In another study conducted in South India by John et al. [19], acute bronchiolitis outbreaks were seen between August and November. A U.K. study [4] reported majority of admissions (93.8%) happened between November and March of each year. However, in a study conducted in Hong Kong,by R.Y.T. Sung et al. [12] found that acute bronchiolitis was most common in the middle of the year, from April to October.

 

In this study 97.1% children in the age group 1-12 months had severe illness.According to Woods-Downes scores, 41.5% (83) of the study population had mild illness, 41% (82) had moderate illness, and 17.5% (35) had severe illness. According to AAP, being young is still the most significant predictor of having severe bronchiolitis. After evaluating risk factors for severe disease, Caroline Breese Hall et al. [5] concluded that children with RSV infection had significantly more severe illness if they were younger. There was no statistically significant correlation between sex and disease severity in this study. However, in their study, Eric A.F. Simoes et al. [20] concluded that male sex was a separate risk factor for severe bronchiolitis.

 

A U.S. study [21] found that while infants under 2500g at birth have a higher chance of dying from bronchiolitis. Low birth weight was independently associated with the severity of bronchiolitis in studies by Chidambaranathan S et al[7], Carlone et al[22], and Yan et al[23]. Low birth weight infants have immature lungs with smaller and narrower bronchioles and a less robust immune system, which makes them prone for severe illness.

 

In this study, lack of breastfeeding was associated with a higher chance of developing a severe disease. Many studies from around the globe have shown the same result. In an Indian study, Das PK et al. [24] made it very evident that not breastfeeding was a substantial risk factor for severe bronchiolitis. Similarly, M A P S Downham et al. [25] found that there was a significantly lower incidence of breastfeeding among infants admitted to hospitals due to RSV infection. Eric A.F. Simoes et al. [20] reported a conflicting finding with the previous studies, stating that there was insufficient evidence to support the idea that not breastfeeding increases the risk of a severe RSV infection. The research by Toms et al. [26], which demonstrated that breast milk varies in its anti-respiratory syncytial virus activity, supported his findings and explained why breastfeeding does not provide total protection.

 

Although it is evident that this protection is not total, breastfeeding appears to provide protection against illnesses severe enough to necessitate hospital admission. However, frank bronchiolitis does occasionally occur in infants who are exclusively breastfed.

 

Parental history of asthma, particularly maternal asthma, is considered a significant risk factor for bronchiolitis in infants, as these children are more prone to lower respiratory infections, including respiratory syncytial virus. However, in this study, parental asthma did not significantly predict the severity of the disease, similar to a study by Carbonell Estrany et al [27].

 

According to a Chinese study [28] and a study by Bryn H. Salt et al [29], early exposure to secondhand environmental tobacco smoke raises the risk of developing a serious respiratory condition like bronchiolitis

 

Earlier research demonstrated that children from joint families had a more severe form of the disease than those from nuclear families, which partially explained the overcrowding. Holman RC et al. [21] reported that a higher birth order was a risk factor for bronchiolitis severity. A study conducted in Italy [30] found that there was a correlation between the number of siblings in the family and the severity of the disease [31].In this study, large family size and families with more than 2 children were statistically significant risk factors for the severity of bronchiolitis.

 

Children from lower socioeconomic backgrounds often present with severe illness [5]. Lower-income individuals were among the otherwise healthy term infants who needed hospitalization [31]. Children from low SES often came from families with higher birth order, poor ventilation, and overcrowding, hence presented with severe forms of illness. The same correlation was seen in this study.

 

As per the study conducted in Italy by Paolo Di Carlo et al. [32], the mean duration of oxygen requirement was 4.9 days compared to 2.36 days in this study. The mean duration of hospital stay in this study was 4 days, similar to the study by Hans-Olav Fjaerli et al.[33].However, in studies by Caroline Breese Hall et al. [5] and S. A. Despande et al. [34], the average duration of hospital stay was 2 days. In this study, the length of hospital stay and the duration of O2 requirement were statistically related to the severity of the disease.

 

The mortality rate in this study was 6.5%.Mortality was more in severe cases, which was statistically significant. Mortality occurs due to severe hypoxemia and respiratory failure. Mortality in Indian studies is higher than in developed nations, ranging from 0.8% to 5.4%. The mortality rate was 5.4% in a study by Ouazoun Coulibaly et al. [35].

 

CONCLUSION

Bronchiolitis contributes to significant morbidity and mortality in infants. Parents should be counseled regarding modifiable risk factors like avoiding bottle feeding, exclusive breastfeeding, avoiding indoor allergens, and the prevention of passive smoking etc.which can increase the severity of illness.RSV has been known to be the major cause of bronchiolitis in Indian children. Despite being among the least harmful respiratory viruses in vitro, RSV is known to cause significant respiratory diseases because of its strong affinity for the bronchial epithelium. A vaccine against RSV can be effective in decreasing the disease burden in infants.

 

Limitations

The causative agent of bronchiolitis in the enrolled children was not studied. It is a single-centre study, generalization of the findings may not be appropriate.

 

Ethical Approval: Taken

Conflict of Interest: None

Acknowledgements: None

 

REFERENCES

  1. Bronchiolitis: Recent evidence on diagnosis and management | pediatrics | American Academy of Pediatrics. Available at: https://publications.aap.org/pediatrics/article abstract/125/2/342/72366/Bronchiolitis.
  2. Jeffrey, A. (2009). Bronchiolitis: An Evidence-Based Approach to Management. Clinical Pediatric Emergency Medicine, 10(2), 75–81.
  3. Hubble, D., & Osborn, G. R. (1941). Acute bronchiolitis in children. Br Med J, 1, 107–110.
  4. Mathew, J. L. (2008). Hypertonic saline nebulization for bronchiolitis. Indian Pediatr, 45, 987–989. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19129567
  5. Joseph J. Zorc, MD, MSCE, Caroline Breese Hall, MD Bronchiolitis: Recent Evidence on Diagnosis and Management Pediatrics Vol. 125 No. 2 February 2010, pp. 342-349
  6. Uyan, A. P., & Ozyurek, H. (2003). Keskin M et al Comparison of two different bronchodilators in the treatment of acute bronchiloitis.
  7. Chidambaranathan, Sindhumathi, & Anantharaman. (2025). A study on the risk factors associated with severity of bronchiolitis in children aged 1 month to 24 months. International Journal of Contemporary Pediatrics12(8), 1409–1413. doi:10.18203/2349-3291.ijcp20252225
  8. Tarik, A. S., Islam, O., & Islam, M. D. (2025). Clinical features and outcomes of bronchiolitis in children: A prospective study. International Journal of Pediatrics and Neonatology7(1), 94–98.
  9. Flores, G., & Horwitz, R. I. (1997). Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics00, 233–239.
  10. Arif, A. (1998). Acute bronchiolitis-a clinical study. Pak Ped J22, 175–177.
  11. Constantopoulos, A. G., & Kafetzis, D. A. (2002). Burden of respiratory syncytial viral infections on paediatric hospitals: a two-year prospective epidemiologicalstudy. EurJClinMicrobiolInfectDis21, 102–107.
  12. Sungryt, C. (1992). Epidemiologyandetiologyofacute bronchiolitis in Hong Kong infants. Epidemiology and Infection108, 147–154.
  13. Iqbal, S. M. J., Afzal, M. F., & Sultan, M. A. (2009). Acute Bronchiolitis: Epidemiological and Clinical Study. Annals15(4).
  14. B, S., Gr, S., Premkumar, B., & Elizabeth, J. (2024). Clinical profile and outcome of bronchiolitis in children with 1-24 months of age. Cureus16(9), e69640. doi:10.7759/cureus.69640
  15. Eposse Ekoube, C., Nsang, H., Épée, E., & Ma Linwa, M. (2024). Predictors of prolonged length of hospital stay and in-hospital mortality in patients aged 1-24 months with acute bronchiolitis in Douala, Cameroon. BMC Pediatr24(1).
  16. Na’amnih, W., Kassem, E., Tannous, S., Kagan, V., Jbali, A., & Hanukayev, E. (2022). Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years. Epidemiol Infect150.
  17. Osman, S., Adeen, A., Hettao, A., Alsiraihi, A., Bader, M., Aloufi, A., … Al-Hindi, M. Y. (2023). Epidemiology and risk factor analysis of children with bronchiolitis admitted to the intensive care unit at a tertiary care center in Saudi Arabia. Children (Basel)10(4).
  18. Weber, M. W., Mulholland, E. K., & Greenwood, B. M. (1998). Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health3(4), 268–280.
  19. Cherian, T. (1990). Bronchiolitis in Tropical South India. Archives of Pediatrics & Adolescent Medicine144(9), 1026. doi:10.1001/archpedi.1990.02150330086028
  20. Simoes, E. A. F. (2003). Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. The Journal of Pediatrics143(5), 118–126. doi:10.1067/s0022-3476(03)00511-0
  21. Holman, R. C., Shay, D. K., & Curns, A. T. (2003). Risk factors for bronchiolitis- associated deaths among infants in the United States. Pediatr InfectDis J22(6), 483–490.
  22. Carlone, G., Graziano, G., Trotta, D., Cafagno, C., Aricò, M. O., & Campodipietro, G. (2023). Bronchiolitis 2021-2022 epidemic: multicentric analysis of the characteristics and treatment approach in 214 children from different areas in Italy. Eur J Pediatr182(4), 1921–1927.
  23. Yan, J., Zhao, L., Zhang, T., Wei, Y., Guo, D., Guo, W., Zheng, J., & Xu, Y. (2023). Development and validation of a nomogram for predicting severe respiratory syncytial virus-associated bronchiolitis. BMC infectious diseases23(1), 249. https://doi.org/10.1186/s12879-023-08179-y
  24. .Das, P. K., Saha, J. B., & Basu, K. (2003). Some clinico-epidemiological aspect of bronchiolitis among infants and young children--a hospital based study. IndianJournalofPublicHealth47, 66–71.
  25. Downham, M. A., Scott, R., Sims, D. G., Webb, J. K., & Gardner, P. S. (1976). Breast-feeding protects against respiratory syncytial virus infections. British medical journal2(6030), 274–276. https://doi.org/10.1136/bmj.2.6030.274
  26. Pullan, C. R., Toms, G. L., Martin, A. J., Gardner, P. S., Webb, J. K. G., & Appleton, D. R. (1980). Breast-Feeding And Respiratory Syncytial Virus Infection. The British Medical Journal, 281(6247), 1034–1036. http://www.jstor.org/stable/25441737
  27. Simoes, E. A., & Carbonell-Estrany, X. (2003). Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. The Pediatric infectious disease journal22(2 Suppl), S13–S20. https://doi.org/10.1097/01.inf.0000053881.47279.d9
  28. . Chen, Y., Li, W., & Yu, S. (1986). Influence of passive smoking on admissions for respiratory illness in early childhood. British medical journal (Clinical research ed.)293(6542), 303–306. https://doi.org/10.1136/bmj.293.6542.303
  29. Kott, K. S., Salt, B. H., McDonald, R. J., Jhawar, S., Bric, J. M., & Joad, J. P. (2008). Effect of secondhand cigarette smoke, RSV bronchiolitis and parental asthma on urinary cysteinyl LTE4. Pediatric pulmonology43(8), 760–766. https://doi.org/10.1002/ppul.20853
  30. Rossi, G. A., Medici, M. C., & Arcangeletti, M. C. (2007). Marcello LanariRisk factors for severe RSV- induced lower respiratory tractinfectionoverfourconsecutiveepidemics. EurJPediatr.
  31. The Increasing Burden and Risk Factors for Bronchiolitis-relatedMedicalVisitsinInfantsEnrolledinaState Healthcare Pediatrics. (2008). 122, 58–64. doi:10.1542/peds.2007-2087
  32. Di Carlo, P., Romano, A., Salsa, L., Gueli, A., Poma, A., Fucà, F., Dones, P., Collura, M., Pampinella, D., Motisi, D., & Corsello, G. (2009). Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy. Italian journal of pediatrics35(1), 11. https://doi.org/10.1186/1824-7288-35-11
  33. .Fjaerli, H.-O. (1993). Hospitalizations for respiratory syncytial virus bronchiolitis in Akershus. In a population- based retrospectivestudyBMCPediatrics2004(Vol. 4). doi:10.1186/1471-2431-4-25
  34. Deshpande, S. A., & Northern, V. (2003). The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Archives of disease in childhood88(12), 1065–1069. https://doi.org/10.1136/adc.88.12.1065
  35. Coulibaly, O. (2023). Prevalence of Acute Bronchiolitis in Infants: About 167 Cases Seen in Pediatric Consultation at the Reference Health Center of the Commune I of Bamako (Mali). Cross Current Int Peer Reviewed J Human Soc Sci9(11), 242–246.
Recommended Articles
Research Article Open Access
Assessment Of Knowledge, Attitude and Practice on Chronopharmacology Among the Clinical Doctors in A Tertiary Care Hospital – A Cross-Sectional Study
2026, Volume-7, Issue 2 : 650-656
Case Report Open Access
Bullet, Blood and Airway – Gun Shot Wound Face Managed with Limited Resources
2026, Volume-7, Issue 2 : 592-596
Original Article Open Access
Morphological and Anatomical Variations of the Coronary Arteries: A Cadaveric Study
2026, Volume-7, Issue 1 : 3161-3166
Research Article Open Access
Cognitive Impairment in Heart Failure with Preserved Ejection Fraction: A Hospital-Based Case–Control Study
2026, Volume-7, Issue 2 : 586-591
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
8 Views
15 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved